Veeva Reinvents Clinical Data Management With a Single Application to Manage All Trial Data
September 17 2018 - 7:12AM
Business Wire
Veeva Vault CDMS delivers on the industry’s
urgent need for complete and concurrent clinical data for faster
insights and execution
2018 Veeva R&D Summit -- Veeva Systems (NYSE:VEEV)
today announced a next-generation cloud application to streamline
clinical data management and accelerate study execution. Veeva
Vault CDMS eliminates the need for multiple tools with a single
clinical data management application that combines coding, EDC,
data cleaning, and reporting. Companies can now have one
application that allows them to manage study build through
execution and gain a complete and concurrent view of all clinical
data within a trial.
“The industry can finally move away from the complex patchwork
of systems and integrations that limit the ability to leverage the
range of clinical data available throughout the course of a trial,”
said Henry Levy, general manager of Veeva Vault CDMS. “Veeva Vault
CDMS will provide the key capabilities companies need to bring
together all their clinical data so research teams can make faster,
more informed decisions.”
Life sciences companies want to use a greater range of data in
trials, but today’s EDC systems only manage a limited volume and
diversity of clinical data.1 This forces organizations to collect,
clean, and analyze data across multiple systems and repositories,
restricting visibility and slowing trial execution.
Veeva Vault CDMS delivers on the need for a complete and
concurrent view of data throughout the trial with one application
for data capture, coding, cleaning, reporting, and management.
Companies can now seamlessly bring data together and have daily
access to all their clinical data during a trial, instead of
waiting weeks or months.
Vault CDMS combines the following capabilities into a single,
modern cloud solution:
- Vault Coder, available today, codes
medical information with speed and accuracy in Vault CDMS.
Streamline medical coding to ensure clinical teams and CROs are
using up-to-date, consistent medical terms across all their
studies.
- Vault EDC, also available now,
maintains and manages all clinical data, including non-CRF data, in
one central location. Build, manage, and run studies faster with a
modern EDC and significantly improve trial execution.
- Vault Data Workbench, planned for
availability in late 2019, will seamlessly bring together all trial
data into a consistently formatted data lake for integrated
cleaning, reporting, and export. Synchronize data automatically
from Vault EDC and Vault Coder. Open APIs are available for a
variety of other data sources such as ePRO, medical imaging, labs,
and randomization.
Vault CDMS is part of Veeva Vault Clinical Suite, which
also includes Vault CTMS, Vault eTMF, and Vault Study Startup, to
unify clinical data management and clinical
operations on a single cloud platform. Veeva’s suite of
unified applications provides global visibility of trial processes
and data for organizations to easily manage their entire trial
portfolio and streamline end-to-end clinical processes.
Vault CDMS is now available with Vault EDC and Vault Coder.
Expanded capability with Vault Data Workbench is planned for
availability in late 2019. Learn more at veeva.com/VaultCDMS.
Additional Information
For more on Veeva Vault CDMS, visit: veeva.com/VaultCDMSConnect
with Veeva on LinkedIn: linkedin.com/company/veeva-systemsFollow
@veevasystems on Twitter: twitter.com/veevasystemsLike Veeva on
Facebook: facebook.com/veevasystems
About Veeva Development Cloud
Veeva Development Cloud is a unified suite of applications for
clinical, regulatory, and quality to help organizations streamline
end-to-end product development processes. Veeva has more than 220
clinical customers, 140 regulatory customers, and 180 quality
customers using applications to drive greater efficiency and
maintain compliance throughout the product lifecycle.2 Learn more
at veeva.com/DevelopmentCloud.
About Veeva Systems
Veeva Systems Inc. is a leader in cloud-based software for the
global life sciences industry and other regulated manufacturers.
Committed to innovation, product excellence, and customer success,
Veeva has more than 650 customers, ranging from the world's largest
pharmaceutical companies to emerging biotechs. Veeva is
headquartered in the San Francisco Bay Area, with offices
throughout North America, Europe, Asia, and Latin America. For more
information, visit veeva.com.
Forward-looking Statements
This release contains forward-looking statements, including the
market demand for and acceptance of Veeva’s products and services,
the results from use of Veeva’s products and services, and general
business conditions, particularly in the life sciences industry.
Any forward-looking statements contained in this press release are
based upon Veeva’s historical performance and its current plans,
estimates, and expectations, and are not a representation that such
plans, estimates, or expectations will be achieved. These
forward-looking statements represent Veeva’s expectations as of the
date of this press announcement. Subsequent events may cause these
expectations to change, and Veeva disclaims any obligation to
update the forward-looking statements in the future. These
forward-looking statements are subject to known and unknown risks
and uncertainties that may cause actual results to differ
materially. Additional risks and uncertainties that could affect
Veeva’s financial results are included under the captions, “Risk
Factors” and “Management’s Discussion and Analysis of Financial
Condition and Results of Operations,” in the company’s filing on
Form 10-Q for the period ended July 31, 2018. This is available on
the company’s website at veeva.com under the Investors section and
on the SEC’s website at sec.gov. Further information on potential
risks that could affect actual results will be included in other
filings Veeva makes with the SEC from time to time.
1 Tufts Center for the Study of Drug Development, 2017 eClinical
Landscape Study2 As of fiscal second quarter ended July 31,
2018
View source
version on businesswire.com: https://www.businesswire.com/news/home/20180917005314/en/
Veeva SystemsRoger Villareal,
925-264-8885roger.villareal@veeva.comorLisa Barbadora,
610-420-3413pr@veeva.com
Veeva Systems (NYSE:VEEV)
Historical Stock Chart
From Mar 2024 to Apr 2024
Veeva Systems (NYSE:VEEV)
Historical Stock Chart
From Apr 2023 to Apr 2024